Umn Pharma

Developing vaccines for influenza

placeYokohama, Kanagawa Prefecture, Japan calendar_todayFounded 2004 groups42 employees language umnpharma.com

Innovation

6 patent families (2 granted) — focus: Physics & computing, Chemistry & metallurgy, Human necessities; filing pace dormant. Cited 103 times.

YearFilings
20153
20162
20171
20182
20192

Investor mix

14 investors on record; 3 have since exited.

Investor typeCountShare
Venture capital857%
Private equity321%
Bank & private debt17%
Other / undisclosed214%
Coming soon